Ambarella, Inc.

Executive Summary

SELL, Medium conviction. Rated SELL, Medium conviction. Ambarella has rebuilt revenue, delivered eight consecutive adjusted EPS beats, and retains a debt-light balance sheet, but FY2026 revenue of $0.4B still produced EPS of -$1.78 and a -44.4% operating margin. The stock is materially off its highs, which argues against chasing downside near earnings, yet the base valuation of $56.08 does not compensate for weak cash-flow quality and a forward valuation that cannot be substantiated from current guidance.

Investment Thesis

Ambarella should be avoided at the current price because the market is still valuing a future edge-AI winner while the reported business remains a recovery project. The stock's 6.5x TTM P/S is slightly below the 6.9x peer average, but that apparent discount is not sufficient. The peer set spans businesses with radically different end markets, profitability, and capital intensity, and the stated 4.6x P/E dispersion confirms that an average peer multiple has limited explanatory value. Ambarella itself has no TTM P/E because it has not generated positive earnings.

The positive case depends on two developments. First, automotive and IoT design wins must move into volume revenue. The company has legitimate silicon credentials, including its early CV5 production milestone, and its historical revenue base had meaningful AI-inference content. Second, volume must produce operating leverage. The LTM margin improvement shows the direction is better than the FY result, but it does not establish a stable earnings model. Investors need proof that gross profit can absorb research, sales, and support costs without relying on narrow non-GAAP EPS beats.

The stock's decline creates a more balanced setup than it had near the highs. At $48.30, the 52-week low, the downside case would already have been substantially reflected. At $62.76, however, the shares have rebounded enough that the engine's base case again points lower, while the next earnings event still lacks disclosed current guidance in the supplied information. Positive options gamma can support a near-term trading range, but it is not an investment thesis.

Conviction is Medium rather than High because Ambarella's balance sheet is not overlevered and AI demand could turn quickly once programs reach production. The rating changes to HOLD or BUY only with quantified guidance demonstrating sustained revenue growth, a clear route to positive operating income, and positive FCF rather than a rounded zero figure. Without those milestones, the company remains an interesting technology asset at an unjustified equity value.

Key Metrics

Financial Strength

The financial position is adequate, not a source of upside. Low balance-sheet leverage and a healthy current ratio reduce refinancing risk, which matters for a company funding advanced chip development through a cyclical recovery. The problem is economic rather than solvency-related: EBITDA is reported as -$0.0B LTM through 2026-07-31, cash is not supplied, and cash-flow quality is weak. Margin progress must continue into actual cash generation before the balance sheet can be viewed as a strategic advantage.

Competitive Position

Ambarella's protection comes from specialized low-power computer-vision SoCs, software stacks, and the lengthy validation required to place chips into cameras and vehicle platforms. The historical CV5 milestone, with more than 500,000 units shipped by FY24 Q4, shows commercial capability in advanced process-node silicon. That advantage is durable only where power efficiency and vision processing matter more than broad compute flexibility; larger AI silicon vendors and customer ASICs constrain pricing power over time.

Management & Guidance

No usable current revenue, gross-margin, operating-expense, or EPS guidance was supplied from the 2026 Q4 call, whose analysis is marked unavailable. That absence matters because the December 1 event is the first opportunity to test whether the recent cadence of estimate beats can support a real earnings model. Historical guidance was precise and largely well managed operationally, but investors should not extrapolate it into FY2027 without updated numbers on production ramps and spending.

Segment Analysis

• Automotive (Not disclosed in supplied current data): Management identified automotive as a sequential-growth contributor in the FY25 Q1 outlook; current automotive revenue and program mix were not supplied.
• IoT (Not disclosed in supplied current data): Management also expected sequential IoT growth in FY25 Q1; this remains the nearer-term edge-AI volume opportunity, but no current segment revenue was provided.
• Geographic revenue (Not disclosed): The supplied dataset does not report country or regional concentration, preventing a reliable assessment of China or customer-geography exposure.

Capital Allocation

Capital allocation is conservative rather than shareholder-return oriented. The supplied LTM figures show $0.0B of FCF, capex, buybacks, and dividends, while Shareholder Returns score only 18/100. With no current cash balance supplied, management should prioritize preserving liquidity and funding high-return design wins rather than initiating repurchases; the historical FY24 Q4 cash and marketable-securities balance of $219.9M is too stale to underwrite today's balance sheet.

Management Execution & Track Record

Management met near-term operational commitments in the FY24 Q4 call: Q4 revenue of $51.6M exceeded the prior midpoint, non-GAAP gross margin of 62.5% met guidance, and non-GAAP OpEx of $44.1M beat the $45M to $48M range. The subsequent record is strong on reported EPS execution, with eight straight beats from November 2024 through September 2026, ranging from 5.3% to 1,200.0% above Street estimates. But the supplied current data do not disclose whether CV5 shipments doubled in FY25, whether CV3 China design-win revenue began in calendar 2026, or whether management reached the roughly $70M quarterly revenue ambition stated in FY24 Q4. Revenue has recovered, but the negative FY2026 profitability outcome means management has earned credibility on quarterly expectations, not yet on the promised conversion from product momentum to durable returns.

Positioning & Flows

Institutional ownership is concentrated, with the top three institutions holding 69.4% and insiders holding 3.2%, which can amplify moves when large holders change risk tolerance. Short interest declined 9.7% to 5,153,912 shares and days-to-cover is only 3.1, so this is not an acute squeeze setup. Positive gamma within 45 days and a zero-gamma level at $57.68 suggest dealer flows may dampen downside above that level, but options positioning does not repair the fundamental valuation gap.

Bull Case

• Adjusted EPS beat consensus in each of the last eight reported quarters, including $0.18 versus $0.171 on September 3, 2026.
• Innovation Investment scores 100/100, consistent with Ambarella's continued positioning in computer-vision SoCs rather than legacy video processors.
• Debt/equity was only 0.02 as of 2026-07-31 and the current ratio was 2.85, giving management time to fund product cycles.
• The share price sits 7.4% below its 200-day average of $67.75, so a credible December outlook can drive a tactical rebound.

Bear Case

• FY2026 net margin was -41.1% and LTM through 2026-07-31 net margin was -13.5%, leaving little evidence that revenue recovery has become durable earnings power.
• Cash Flow Quality scores just 9/100, while LTM FCF and capex are both reported as $0.0B, providing no demonstrated internally generated funding for growth.
• The peer P/E average is 37.3, but dispersion is a very wide 4.6x, making peer-multiple valuation a weak anchor for an unprofitable company.
• Short interest is 12.24%, or 5.15M shares, reflecting substantial skepticism and potential volatility if the next outlook disappoints.

Valuation & Price Target

Engine price target $56.08 (-10.6% vs current), High confidence.

• P/S Multiple: $54.67 (45% weight)
• Quality-adjusted: $59.25 (20% weight)

The rating aligns with the quantitative SELL baseline and its High-confidence $56.08 target. A divergence toward BUY would require evidence that current revenue guidance supports positive forward earnings and cash generation, neither of which is available in the supplied current-call material; the LTM loss profile instead supports the engine's sales-quality discount. Sell-side consensus reads Strong Buy, with 2 buys and 2 holds from only 4 firms, but that is explicitly low-signal context and does not outweigh the missing forward-profit proof or the 43/100 quality score.

Risk Assessment

Risk score 56/100 (Moderate). The central risk is that edge-AI design wins fail to translate into operating leverage, leaving a company with an LTM operating margin of -14.3% valued at 6.5x TTM sales.

The Bottom Line

AMBA rates a SELL for the next 6-12 months. The company has genuine edge-AI assets and a clean enough balance sheet to survive a longer ramp, but investors are being asked to underwrite profitability that the available data do not show. The December outlook can support a tactical bounce, particularly from a depressed 52-week position, but it needs to show more than another adjusted EPS beat. A sustained positive operating-margin path, disclosed production revenue from AI programs, and positive FCF would change the view.